Benfotiamine API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Benfotiamine API Manufacturer in India

Product Overview

Benfotiamine is a synthetic, fat-soluble derivative of thiamine (Vitamin B1) belonging to the class of allithiamine-related compounds. It is developed to provide a form of thiamine with different absorption and bioavailability characteristics compared with conventional water-soluble thiamine salts.

Benfotiamine is widely studied for its role in thiamine metabolism, cellular energy production and biochemical pathways associated with glucose metabolism. It is particularly relevant to pharmaceutical and nutritional research involving diabetic complications, peripheral nerve function and oxidative stress.

After absorption, Benfotiamine undergoes conversion through metabolic processes that ultimately contribute to the availability of thiamine and its active coenzyme form, thiamine diphosphate (TDP), also known as thiamine pyrophosphate (TPP). This coenzyme plays an important role in carbohydrate metabolism and energy production.

Benfotiamine is also investigated for its potential influence on biochemical pathways associated with advanced glycation end products (AGEs), oxidative stress and inflammatory signalling. These research areas have made it an important compound in studies involving metabolic health and nerve-related conditions.

Important distinction: Benfotiamine is chemically different from thiamine hydrochloride, thiamine mononitrate and other Vitamin B1 salts. Its chemical identity, CAS number and analytical specifications should be maintained separately.

Chemical Identity and Composition

Benfotiamine has the molecular formula C₁₉H₂₃N₄O₆PS, a molecular weight of approximately 466.45 g/mol, and CAS number 22457-89-2.

Its chemical structure is based on a thiamine-related molecule containing a phosphorus-containing substituent and a sulfur-containing heterocyclic system. The compound is commonly described as a lipid-soluble thiamine derivative.

Benfotiamine is also known by the chemical name S-benzoylthiamine O-monophosphate. Its structural characteristics distinguish it from conventional thiamine salts and contribute to its different physicochemical and absorption properties.

Chemical identity details:

  • Product name: Benfotiamine
  • CAS number: 22457-89-2
  • Molecular formula: C₁₉H₂₃N₄O₆PS
  • Molecular weight: 466.45 g/mol
  • Chemical name: S-benzoylthiamine O-monophosphate
  • Chemical class: Synthetic thiamine derivative
  • Vitamin category: Vitamin B1 derivative
  • Compound category: Lipid-soluble thiamine-related compound
  • Primary biochemical relevance: Thiamine metabolism and carbohydrate metabolism

Mechanism of Action

Benfotiamine is investigated for its role in increasing thiamine availability and influencing metabolic pathways associated with glucose utilisation.

Following absorption, Benfotiamine is converted through enzymatic and metabolic processes into thiamine-related compounds. Thiamine is subsequently converted into thiamine diphosphate (TDP), the biologically active coenzyme form required by several enzymes involved in carbohydrate metabolism.

The general mechanism can be understood through the following steps:

  1. Benfotiamine is administered through an appropriate oral formulation.
  2. The compound undergoes absorption and metabolic conversion.
  3. Thiamine-related metabolites become available in the body.
  4. Thiamine is converted into its active coenzyme form, thiamine diphosphate.
  5. Thiamine diphosphate supports enzymes involved in carbohydrate metabolism and cellular energy production.
  6. Research suggests that Benfotiamine may influence biochemical pathways associated with excess glucose metabolism.
  7. Its effects on oxidative stress, advanced glycation end products and inflammatory pathways continue to be investigated.

One important research pathway involves transketolase, a thiamine-dependent enzyme in the pentose phosphate pathway. Increased transketolase activity has been proposed as one mechanism through which Benfotiamine may influence the accumulation of certain glucose-derived metabolic intermediates.

These mechanisms are subjects of scientific research and should not be interpreted as proof that Benfotiamine prevents or treats diabetic complications in every clinical setting.

Pharmaceutical and Research Applications

Benfotiamine is used in the development of pharmaceutical and nutritional formulations associated with Vitamin B1 supplementation and thiamine-related metabolic research. Its lipid-soluble characteristics distinguish it from conventional thiamine salts and make it relevant to formulation studies involving alternative thiamine delivery systems.

Its applications and research areas include:

  • Oral tablet and capsule formulation development.
  • Vitamin B1 derivative formulations.
  • Research involving thiamine metabolism and cellular energy production.
  • Studies of glucose metabolism and carbohydrate utilisation.
  • Research into peripheral nerve function and diabetic neuropathy.
  • Investigation of oxidative-stress pathways.
  • Studies involving advanced glycation end products (AGEs).
  • Research into transketolase activity and the pentose phosphate pathway.
  • Nutritional and pharmaceutical formulation research.
  • Analytical research involving thiamine derivatives.

Benfotiamine has been investigated in clinical and experimental studies involving diabetic neuropathy and other complications associated with diabetes. However, evidence of clinical effectiveness varies by condition and study, and research findings should not be presented as a guarantee of therapeutic benefit.

Product Benefits and Technical Features

  • Thiamine derivative: Benfotiamine is a synthetic derivative of Vitamin B1.
  • Lipid-soluble characteristics: It has different physicochemical and absorption characteristics from conventional water-soluble thiamine salts.
  • Metabolic relevance: It contributes to research involving thiamine-dependent enzymes and carbohydrate metabolism.
  • Transketolase research: It is studied for its potential influence on transketolase activity.
  • Oxidative-stress research: It is investigated in relation to cellular oxidative-stress pathways.
  • Defined chemical identity: It has an established CAS number, molecular formula and molecular weight.
  • Pharmaceutical formulation relevance: It is used in research and development of oral formulations.
  • Analytical characterization: It can be evaluated through appropriate chromatographic and spectroscopic methods.

Quality and Analytical Considerations

Benfotiamine intended for pharmaceutical applications should be evaluated against an appropriate approved specification. Quality assessment should establish the identity, purity, strength and consistency of the API.

Important quality attributes may include:

  • Description and physical appearance.
  • Identification by suitable analytical techniques.
  • Assay or chromatographic purity.
  • Related substances and degradation products.
  • Water content or loss on drying, where applicable.
  • Residual solvents, where applicable.
  • Elemental impurities, where applicable.
  • Phosphate-related impurities, where relevant to the validated method.
  • Stability under the specified storage conditions.
  • Particle-size distribution, when relevant to the intended formulation.

HPLC or UPLC may be used for assay and related-substance evaluation, depending on the approved analytical method. Suitable spectroscopic methods can support identity confirmation.

Because Benfotiamine contains a phosphate group and a thioester-containing structure, analytical methods should be appropriate for the compound's chemical form and potential degradation pathways. Stability-indicating methods may be relevant when evaluating degradation during storage and processing.

Important IP grade clarification: The chemical identity of Benfotiamine is established, but I could not verify a current official Indian Pharmacopoeia monograph or numerical IP acceptance limits for this ingredient from the publicly available references reviewed. The Indian Pharmacopoeia Commission identifies IP as the official source of applicable drug standards. Therefore, the IP grade designation should be confirmed against the current official IP Online monograph or the approved product documentation before publication. Do not assume that a supplier's 98% research-grade purity is an IP assay specification.

Why Product Documentation Matters

Product documentation is important for verifying the identity, quality and traceability of Benfotiamine API.

A Certificate of Analysis (COA) should provide batch-specific test results, including identification, assay, related substances and other applicable quality attributes.

A Safety Data Sheet (SDS) provides information about potential hazards, safe handling, storage, exposure controls and emergency precautions.

Depending on the intended pharmaceutical application, supporting documentation may include:

  • Batch-specific Certificate of Analysis.
  • Safety Data Sheet.
  • Approved product specification.
  • Analytical method references.
  • Related-substance and impurity profile.
  • Residual-solvent information, where applicable.
  • Stability and storage information.
  • Regulatory and quality declarations, where available.

All documentation should identify the correct Benfotiamine chemical form, CAS number 22457-89-2, molecular formula and batch-specific analytical results.

Key Product Highlights

  • Product: Benfotiamine
  • CAS Number: 22457-89-2
  • Molecular Formula: C₁₉H₂₃N₄O₆PS
  • Molecular Weight: 466.45 g/mol
  • Chemical Name: S-Benzoylthiamine O-monophosphate
  • Synonyms: Benzoylthiamine monophosphate, S-benzoylthiamine monophosphate, BTMP
  • Chemical Class: Synthetic thiamine derivative
  • Vitamin Category: Vitamin B1 derivative
  • Product Category: Pharmaceutical and nutritional ingredient
  • Primary Research Areas: Thiamine metabolism, glucose metabolism and oxidative-stress pathways
  • Dosage Form Applications: Oral tablets and capsules

Product Enquiries

For Benfotiamine enquiries, contact Swapnroop Drugs & Pharmaceuticals with your required grade, quantity, target purity, intended application and destination market. Product availability, documentation and commercial terms must be confirmed by the sales team.

Frequently Asked Questions

What is Benfotiamine?

Benfotiamine is a synthetic derivative of thiamine (vitamin B1), also known as S-benzoylthiamine O-monophosphate.

What is the CAS number of Benfotiamine?

The CAS Registry Number is 22457-89-2.

What is the molecular formula of Benfotiamine?

Its molecular formula is C19H23N4O6PS.

What is the molecular weight of Benfotiamine?

Its average molecular weight is approximately 466.45 g/mol.

What does Benfotiamine IP mean?

It indicates a claim that the material meets the applicable Indian Pharmacopoeia standard. Compliance must be verified for the supplied grade.

What is Benfotiamine used for?

Benfotiamine is a thiamine derivative used in certain vitamin-related products and investigated in biomedical research. Specific therapeutic claims require appropriate supporting evidence and regulatory authorization.

What purity is available for Benfotiamine?

Purity depends on the product grade and approved specification. Buyers should review the applicable specification and batch COA.

Which documents can buyers request?

Customers can enquire about the applicable COA, SDS, product specification and supporting technical documents, subject to availability.

How can customers enquire about Benfotiamine?

Customers can contact Swapnroop Drugs & Pharmaceuticals with their required grade, quantity, intended application and documentation requirements.

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0%–102.0%
Loss on Drying NMT 1.5%
Residue on Ignition NMT 0.20%
Heavy Metals NMT 20 ppm
pH (1% Solution) 5.0–7.0
Individual Impurity NMT 0.10%
Total Impurities NMT 1.0%
Melting Point 162–165°C
Get Bulk Quote via WhatsApp
chatbot/chatbot.js" defer>